Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

Keywords

Medicine, Head and neck cancer, Oncology, Head and neck, Internal medicine

References

• Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: How and when?Theodore K. Miller, Roger B. Winston — 2008
• Emerging biomarkers in head and neck cancer in the era of genomics张森奉 — 2015
• Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to CetuximabWen‐Shao Chang, Kazutoshi Komatsu — 2016
• Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neckAthanassios Argiris, Yi Li, Arlene A. Forastiere — 2004
• Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome.Yasheng Zhu, Shancheng Ren, Taile Jing — 2015
• Modeling Survival Data Extending The Cox ModelHaiqun Lin, Daniel Zelterman — 2016
• Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neckMarta Persson, Ywonne Andrén, Joachim Mark — 2009
• The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach.Jon Cacicedo, Arturo Navarro-Martín, Filippo Alongi — 2014
• The MLL recombinome of acute leukemiasClaus Meyer, Björn Schneider, Stephan M. Jakob — 2006
• Surgical Salvage of Recurrent Cancer of the Head and NeckMark Zafereo — 2014
• Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.David D. W. Twa, Fong Chun Chan, Susana Ben‐Neriah — 2013
• The landscape and therapeutic relevance of cancer-associated transcript fusionsKosuke Yoshihara, Qing Wang, Wandaliz Torres‐García — 2014
• Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies.Lisa Licitra, Stephan Störkel, Keith M. Kerr — 2013
• Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and InterpretationDaniele Merico, Ruth Isserlin, Oliver Stueker — 2010
• The MLL recombinome of acute leukemias in 2013Claus Meyer, Jörg Hofmann, Thomas Burmeister — 2013
• Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME studyLisa Licitra, Ricard Mesı́a, Fernando Rivera — 2010
• Platinum-based chemotherapy plus cetuximab in head and neck cancer.Jan B. Vermorken, Ricard Mesı́a, Fernando Rivera — 2008
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesAravind Subramanian, Pablo Tamayo, Vamsi K. Mootha — 2005
• TopHat-Fusion: an algorithm for discovery of novel fusion transcriptsDaehwan Kim, Steven L. Salzberg — 2011
• DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a reviewYu Chen, Chu Chen — 2008

Cited by

• Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature.Paolo Bossi, Salvatore Alfieri, Primož Strojan — 2019
• Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implicationsCai Han, Lin-Yu Sun, Wentao Wang — 2019
• Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic ReviewW. W. B. de Kort, Sacha Spelier, Lot A. Devriese — 2021
• Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancerDavid Sánchez-Marín, Macrina B. Silva-Cázares, Fany Iris Porras-Reyes — 2023
• Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implicationsBhasker Dharavath, Ashwin Butle, Akshita Chaudhary — 2024
• A Transcriptomic Analysis of Laryngeal DysplasiaFausto Maffini, Daniela Lepanto, Francesco Chu — 2024

Related papers

• Should cetuximab replace cisplatin in head and neck cancer?Karen Rowan — 2010
• PCN86 COST-EFFECTIVENESS OF CETUXIMAB COMBINED WITH RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER IN TAIWANA.W. Chan, HW Leung, S-J Lin — 2010
• More on cetuximab in head and neck cancer.Loren K. Mell, Ralph R. Weichselbaum — 2007
• Oxytocin dose requirements after caesarian delivery&NA; — 2006
• Polymorphism in epidermal growth factor is related to clinical outcomes of metastatic colorectal cancer patients treated with cetuximab: a systematic review and meta-analysis.Xiaoli Lü, Xiaowan Chen, Jingxu Sun — 2015
• Cetuximab Therapy for Head and Neck Squamous Cell CarcinomaTravis D. Reeves, Elizabeth G. Hill, Kent Armeson — 2011
• Cetuximab: a standard approach to the first-line treatment of recurrent and/or metastatic and locally advanced squamous cell carcinoma of the head and neckJacques Bernier — 2011
• Cetuximab: a standard approach to the first-line treatment of recurrent and/or metastatic and locally advanced squamous cell carcinoma of the head and neckJacques Bernier — 2011